R. Niven

发表

Characterization and In Vivo Testing of a Heterogeneous Cationic Lipid-DNA Formulation

Janet G. Smith, T. Wedeking, J. Vernachio, 1998, Pharmaceutical Research.

Prediction and experimental determination of solute output from a Collison nebulizer.

R. Niven, A. Ip, 1994, Journal of pharmaceutical sciences.

Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD

Claus-Michael Lehr, William Doub, Per Bäckman, 2016 .

Pulmonary absorption of polyethylene glycolated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF)

R. Niven, K. Whitcomb, Linda Shaner, 1994 .

Development and use of an in vitro system to evaluate inhaler devices

R. Niven, A. Ip, F. Lott, 1994 .

Generation of aerosolized drugs.

R. Wolff, R. Niven, 1994, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

Some functional aspects of air-jet nebulizers

R. Niven, J. Brain, 1994 .

Pulmonary Absorption of Recombinant Methionyl Human Granulocyte Colony Stimulating Factor (r-huG-CSF) After Intratracheal Instillation to the Hamster

R. Niven, F. Lott, Judith M. Cribbs, 1993, Pharmaceutical Research.

Lung deposition and pharmacokinetics of nebulized cyclosporine in lung transplant patients.

T. Corcoran, S. Dilly, R. Niven, 2014, Journal of aerosol medicine and pulmonary drug delivery.

Some Factors Associated with the Ultrasonic Nebulization of Proteins

T. Arakawa, R. Niven, S. Mittelman, 2004, Pharmaceutical Research.

Modulated Drug Therapy with Inhalation Aerosols: Revisited

R. Niven, 2003 .

Biodistribution of radiolabeled lipid-DNA complexes and DNA in mice.

J. G. Smith, T. Wedeking, R. Niven, 1998, Journal of pharmaceutical sciences.

Production and Characterization of Large Porous Particles for Pulmonary Drug Delivery

R. Niven, J. Mintzes, J. Nice, 1998 .

Protein nebulization: I. Stability of lactate dehydrogenase and recombinant granulocyte-colony stimulating factor to air-jet nebulization

T. Arakawa, Christine E Farrar, R. Niven, 1994 .

Acetazolamide and furosemide attenuate asthma induced by hyperventilation of cold, dry air.

E. Israel, J. Drazen, R. Niven, 1992, The American review of respiratory disease.

Prospects and challenges: inhalation delivery systems.

R. Niven, 2013, Therapeutic delivery.

Safety and toxicology of cyclosporine in propylene glycol after 9-month aerosol exposure to beagle dogs.

R. Niven, Crystal M. Briscoe, H. Raff, 2011, Journal of aerosol medicine and pulmonary drug delivery.

A method for preparing chelate-cytokine conjugates with retention of protein structure, biological activity, and pharmacokinetic properties.

M. Treuheit, M. Woodward, D. C. Litzinger, 1995, Journal of immunological methods.

Erratum to: Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD

W. Doub, M. Sakagami, C. Lehr, 2016 .

Protein nebulization. II. Stabilization of G-CSF to air-jet nebulization and the role of protectants

T. Arakawa, M. Treuheit, R. Niven, 1996 .

Nebulization of Liposomes. I. Effects of Lipid Composition

H. Schreier, R. Niven, 1990, Pharmaceutical Research.

Pulmonary effects of chronic exposure to liposome aerosols in mice.

H. Schreier, R. Niven, M. Kaltenbach, 1993, Experimental lung research.

The Pulmonary Absorption of Aerosolized and Intratracheally Instilled rhG-CSF and monoPEGylated rhG-CSF

R. Niven, A. Ip, K. Whitcomb, 1995, Pharmaceutical Research.

KL4‐surfactant prevents hyperoxic and LPS‐induced lung injury in mice

R. Niven, C. Solomides, D. Jain, 2006, Pediatric pulmonology.

Nebulization of Liposomes. II. The Effects of Size and Modeling of Solute Release Profiles

H. Schreier, R. Niven, M. Speer, 1991, Pharmaceutical Research.

Nebulization of Liposomes. III. The Effects of Operating Conditions and Local Environment

H. Schreier, R. Niven, Teresa M. Carvajal, 1992, Pharmaceutical Research.

Solute Absorption from the Airways of the Isolated Rat Lung. II. Effect of Surfactants on Absorption of Fluorescein

R. Niven, P. Byron, 2004, Pharmaceutical Research.

NEBULIZATION OF LIPOSOMES: I-EFFECT OF LIPID COMPOSITION

H. Schreier, R. Niven, 1990 .

Toward managing chronic rejection after lung transplant: the fate and effects of inhaled cyclosporine in a complex environment.

R. Niven, 2011, Advanced drug delivery reviews.

The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation

R. Niven, Ralph W. Niven, David A. Edwards, 1996 .

INHALED IMATINIB FOR PULMONARY ARTERIAL HYPERTENSION CLINICAL TRIAL: DESIGN OF THE IMPACT PHASE 2B/3 STUDY DESIGN

M. Humbert, Z. Jing, Ben Dake, 2022, Chest.

Stability of recombinant consensus interferon to air-jet and ultrasonic nebulization.

T. Arakawa, R. Niven, A. Ip, 1995, Journal of pharmaceutical sciences.

AV-101, a novel inhaled dry-powder formulation of imatinib, in healthy adult participants: a phase 1 single and multiple ascending dose study

M. Hoeper, R. Niven, V. McLaughlin, 2022, ERJ Open Research.

Delivery of biotherapeutics by inhalation aerosol.

R. Niven, R W Niven, 1995, Critical reviews in therapeutic drug carrier systems.

Formulation and in vitro performance of liposome powder aerosols

H. Schreier, R. Niven, A. Hickey, 1993 .

Solute Absorption from the Airways of the Isolated Rat Lung. III. Absorption of Several Peptidase-Resistant, Synthetic Polypeptides: Poly-(2-Hydroxyethyl)-Aspartamides

R. Niven, F. Rypáček, P. Byron, 1990, Pharmaceutical Research.

Erratum to: Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD

W. Doub, M. Sakagami, C. Lehr, 2016 .

Aerodynamics and aerosol particle deaggregation phenomena in model oral-pharyngeal cavities

K. Englmeier, J. Heyder, R. Langer, 1996 .

Systemic Absorption and Activity of Recombinant Consensus Interferons After Intratracheal Instillation and Aerosol Administration

R. Niven, Jennifer Liu, K. Whitcomb, 1995, Pharmaceutical Research.

Pulmonary Delivery of Powders and Solutions Containing Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) to the Rabbit

R. Niven, A. Ip, F. Lott, 1994, Pharmaceutical Research.

Use of perfluorocarbon (fluorinert) to enhance reporter gene expression following intratracheal instillation into the lungs of Balb/c mice: implications for nebulized delivery of plasmids.

R. Niven, A. Das, 2001, Journal of pharmaceutical sciences.

Toward development of a non-viral gene therapeutic.

Yilin Zhang, Janet G. Smith, R. Niven, 1997, Advanced drug delivery reviews.

The Influence of Sodium Glycocholate and Other Additives on the in vivo Transfection of Plasmid DNA in the Lungs

Daniel J. Freeman, R. Niven, 1996, Pharmaceutical Research.

Early View

Ben Dake, R. Niven, V. McLaughlin, 2022 .